Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli

Background: Ciprofloxacin, a fluoroquinolone, targets two essential bacterial enzymes, DNA gyrase and topoisomerase IV. Plasmid-borne qnr genes, encoding proteins that protect DNA gyrase and topois ...